- Pfizer Sees 2025 Revenue in Line With Wall Street Views The Wall Street Journal
- Pfizer Stock Jumps On Mixed, But ‘Marginally Encouraging,’ 2025 Outlook Investor’s Business Daily
- Pfizer Stock Rises as Drug Giant Sees 2025 Revenue of $61 Billion to $64 Billion Barron’s
- Pfizer forecasts 2025 profit in line with expectations as it seeks turnaround CNBC
- Pfizer Signals Growth in FY 2025 Guidance, Projects Revenue Up to $64 Billion Yahoo Finance
Powered by WPeMatico